Disopyramide, procainamide, and quinidine are considered third-line agents in this situation.

这些情况下，双异丙吡胺、普胺和奎尼丁可为三线药物。

The clinician may consider disopyramide, procainamide, or quinidine on an individual basis.

临基于个体化考虑可能会选用双异丙吡胺、普胺或奎尼丁。